ALVR Overview

Investor Alert: Bragar Eagel & Squire, P.C. is investigating potential claims against AlloVir, Inc. (NASDAQ:ALVR) for long-term stockholders who may have suffered losses between March 22, 2022, and December 21, 2023, following a class action complaint filed on March 19, 2024.

Allegations of Misconduct: The complaint alleges that AlloVir's board made false statements regarding the efficacy of its posoleucel Phase 3 studies, which were ultimately discontinued due to concerns about meeting primary endpoints, leading to a significant drop in the company's stock price.

Legal Investigation: Bragar Eagel & Squire, P.C. is investigating potential claims against AlloVir, Inc. on behalf of long-term stockholders after a class action complaint was filed alleging that the company made false statements regarding its posoleucel Phase 3 studies.

Stock Price Impact: Following the announcement of discontinuing the posoleucel Phase 3 studies due to efficacy concerns, AlloVir's stock price plummeted by 67.38%, closing at $0.76 per share on December 22, 2023.

Investigation of Companies: Halper Sadeh LLC is investigating AlloVir, William Penn Bancorporation, Interpublic Group, and 180 Degree Capital for potential violations of federal securities laws and breaches of fiduciary duties related to their mergers and sales.

Shareholder Rights: The firm encourages shareholders from these companies to contact them for legal rights and options regarding the proposed transactions, offering services on a contingent fee basis.

Investigation of Companies: Halper Sadeh LLC is investigating potential securities law violations and fiduciary duty breaches related to the sales and mergers of several companies, including Interpublic Group, AlloVir, William Penn Bancorporation, and AeroVironment.

Legal Support for Shareholders: The firm offers free consultations to shareholders affected by these transactions, aiming to seek increased compensation or other benefits on their behalf, with no upfront legal fees required.

Mergers and Shareholder Votes: Monteverde & Associates PC is investigating several proposed mergers involving companies like AlloVir, Interpublic Group, AeroVironment, and William Penn Bancorporation, with shareholder votes scheduled from March 12 to April 2, 2025.

Legal Services Offered: The firm emphasizes its successful track record in recovering money for shareholders and encourages individuals with concerns about these mergers to contact them for free information.

Investigation of Companies: Halper Sadeh LLC is investigating potential violations of federal securities laws related to the sales and mergers of several companies, including Cross Country Healthcare, William Penn Bancorporation, EMCORE Corporation, and AlloVir, Inc.

Legal Rights for Shareholders: The firm encourages affected shareholders to contact them for free consultations regarding their legal rights and options, emphasizing that they operate on a contingency fee basis.